02186.HK
Luye Pharma Group Ltd.
HKSE · Healthcare · Drug Manufacturers - General · CN
HKD 1.59
+0.96%Year over year
Reported trailing growth
- Revenue
- -0.6%
- EBITDA
- +2.8%
- EBIT
- +1.2%
- EPS
- +64.6%
- Free cash flow
- -6.8%
- Operating cash flow
- -58.4%
Forward estimates
Based on analyst estimates
- Revenue
- -47.1%
- EBITDA
- -43.2%
- EPS
- -64.8%
Three-year CAGR
- Revenue
- +1.8%
- EBITDA
- +4.3%
- EBIT
- +12.2%
- Net income
- +0.8%
- EPS
- -2.0%
- Free cash flow
- +16.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026